Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ureteral Neoplasms × Plasmapheresis × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1

Interventions

Gemcitabine 9 Specimen Handling 8 enfortumab vedotin 7 Cisplatin 7 pembrolizumab 6 Magnetic Resonance Spectroscopy 6 Carboplatin 5 vinflunine 4 avelumab 4 Biopsy 3 cabozantinib 2 atezolizumab 2 Standard of Care 2 Ramucirumab 2 Platinum 2 Nivolumab 2 Ipilimumab 2 Immunoglobulin G 2 Docetaxel 2 Disulfides 2 CTLA-4 Antigen 2 Bortezomib 2 1,2-diaminocyclohexaneplatinum II citrate 2 vandetanib 1 tocilizumab 1 tamibarotene 1 rucaparib 1 genexol-PM 1 eribulin 1 erdafitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07087860 2025-12-09

RECIPE-B1

Mayo Clinic

Phase 2 Recruiting

Urinary Bladder Neoplasms, Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡